Full cycle of development and production of pharmaceutical products and dietary supplements

Development and contract manufacturing of dietary supplementsDrug development and contract manufacturingFull project support — from concept to mass productionРазработка составов и технологийLaboratory researchProduct registration

Clinical studies

и системный анализ научных публикаций. Сопровождение сертификации для вынесения информации об эффективности и полезных свойствах на упаковку БАД

Our strengths

End-to-end brand launch

from idea to mass production

От 5000

units per batch

GMP, ISО

compliance with Russian and international standards

«Chestny znak»

release with national product labeling system

Clinical studies

we collaborate with leading medical centers

Delivery

operations across Russia and the CIS

Why choose us?

We are constantly seeking new ways to improve patients' quality of life. Our success is built on scientific innovations, which we actively integrate into the production processes of our products

More about us

Full transparency

24/7 video monitoring of the production process

In-house R&D center

PhD-level staff

Full-cycle services

From formulation development to documentation for entry into Russian and international markets

Professional team

Key technical and production personnel with 15+ years of industry experience

Quality control

Batch-by-batch quality control of manufactured products

About us

For over 20 years, we have successfully balanced contract manufacturing with our own product development

Partners about us

  • Throughout our collaboration, the MBP team has consistently demonstrated a high level of professionalism. The company is staffed with highly qualified specialists, equipped with modern technology, and is committed not only to maintaining high quality standards but also to taking into account the client’s specific requirements.

    We recommend MBP as a reliable manufacturer that consistently shows competence and efficiency at every stage of the work process.

    We highly value our strong partnership and look forward to continuing our cooperation.

    K. V. Chernov General Director, LLC "EcoPharmInvest"
  • MBP is one of the most reliable and high-class manufacturing facilities in Russia. Since the beginning of our partnership, we have consistently received products that fully comply with all technical documentation, as well as international quality and safety standards.

    The company’s team demonstrates professionalism and responsibility at every stage — from technology development to production. We especially appreciate their strict quality control: each batch undergoes thorough testing, ensuring the reliability and safety of the final product.

    At MBP, we highly value the transparency and efficiency of their processes, their flexibility in adapting to individual client needs, and their strict adherence to deadlines. They are a trustworthy partner who is both pleasant and profitable to work with. We are confident that our continued cooperation will open new opportunities for both us and our clients.

    G. M. Abraamyan General Director, LLC "Giga Pharm"
  • We would like to thank MBP for the development and industrial production of our products, as well as for their loyal and client-oriented approach. The company’s team carried out the full cycle of work — from selecting and refining product formulations to registration and mass production — ensuring strict compliance with quality requirements at every stage of our cooperation.

    We highly appreciated the deep expertise, professionalism, and flexible approach to client needs demonstrated by the company's employees. We recommend MBP as a reliable and responsible partner in the field of contract manufacturing.

    V. D. Astakhova General Director, LLC "Octoherb Pharma"
  • In our experience, MBP is a reliable contractor you can count on.

    All work is completed within the agreed timeframes and to a high standard of quality.

    L. M. Gapoyan Business Development Director, LLC "29 February"
  • We express our gratitude to MBF for their productive collaboration with the National Scientific Center for Pharmacovigilance (ANO) in the field of pharmacovigilance.

    We would like to highlight the team's responsibility and attention to the tasks of joint projects, which helps ensure seamless cooperation between our organizations.

    Throughout our partnership, MBP has proven to be a reliable partner.

    We wish you continued dynamic growth, new achievements, as well as success and prosperity.

    A. E. Krasheninnikov General Director, National Scientific Center for Pharmacovigilance (ANO)
  • We would like to express our sincere gratitude for your contribution to our collaboration, which has proven to be highly productive.

    We would especially like to highlight your high level of professionalism, strong organizational skills, clear task formulation, and the provision of all necessary information to achieve project goals within the established deadlines. An important contribution from your side was the company’s openness to dialogue, its constructive nature, and your willingness to engage in tolerant discussions of even the most complex issues during project implementation. This created an atmosphere of trust and mutual understanding, which positively impacted the results of our collaboration. It is also worth noting that MBP consistently met all deadlines and ensured timely payments, which is a crucial factor for the successful operation of any business. We highly value your attention to detail and the professional approach demonstrated throughout our cooperation. Working with MBP has been not only productive but also a truly pleasant experience.

    We wholeheartedly recommend MBP as a reliable and responsible partner and look forward to continuing our cooperation in the future.

    V. A. Khazanov General Director, LLC "Ifar"
  • Since 2020, LLC "Epipharma" has been a client of JSC "MBP". During this time, we have successfully utilized a wide range of services provided by JSC "MBP", including product development, preclinical and clinical trials, registration, and mass production of pharmaceutical products.

    At every stage of our collaboration, JSC "MBP" has proven to be a reliable partner, demonstrating respect for the priorities, time, and budget of its clients.

    We express our gratitude to JSC "MBP" for their consistently high level of professionalism, quality of services, punctuality, and efficiency in addressing arising challenges.

    M. S. Petukhov General Director, LLC "Epipharma"
  • On behalf of the research team of our university, please accept our warmest words of gratitude for your reliable partnership and substantial support in the implementation of the significant project for the production of the Active Pharmaceutical Ingredient (API) of a new medicinal product. Your company has demonstrated benchmark standards of work in the pharmaceutical industry, which has allowed us not only to achieve our goals but also to strengthen our confidence in having made the right choice of partner.

    Our experience of working together has proven that the alliance between the university's research and educational potential and MiraxBioPharma's strong manufacturing base is an extremely promising model for implementing other innovative projects in the fields of biomedicine and pharmacy.

    We wish your company confident growth, dynamic development across all areas of your operations, and outstanding professional achievements, and we wish its employees health and well-being.
    May our partnership grow stronger and bring mutual success!

    A. S. Fedonnikov Vice-Rector for Research at the V.I. Razumovsky Saratov State Medical University

Frequently asked questions

Contract manufacturing involves producing items under your brand at our manufacturing facility. We can manage the entire project on a turnkey basis, or step in at any specific stage—whether that means developing a formula, selecting a product format, preparing documentation, or handling the technology transfer to move the production process to our facilities.

We can create an analogue of a product available on the market for you (a complete analogue in terms of components, or an alternative composition with the same effect). We can develop a complementary dietary supplement to complement your cosmetic line or in line with the logic of your service.

Подробнее об этом вопросе

The minimum order quantity is 5,000 units of the product.

Подробнее об этом вопросе

The timeframe for launching a new product is individual and largely depends on the complexity of the project, the specifics of the raw materials, and the order volume.

При начале сотрудничества, мы согласуем с вами сроки планируемых отгрузок и заранее поставим ваш продукт в производственный план. Если сформировать годовой календарь отгрузок затруднительно, мы рекомендуем формировать новые заявки за 2-3 месяца до желаемой даты отгрузки, чтобы встроить изготовление вашего продукта в очередь производственного процесса и процедур необходимого контроля.

As soon as the necessary final inspection is completed and the quality documentation is prepared, we will be ready to ship the ordered products to you. Delivery terms are discussed on an individual basis and specified in the contract.

Подробнее об этом вопросе

Every project is unique, so we can only provide estimated timelines.

Launching a new dietary supplement brand on the market is quite quick. If the product is selected from our list of ready‑made and registered formulations, the customer only needs to approve the design and place an order for packaging materials. Such orders are completed within 2–3 months.

If a new composition is planned, its scientific and technological development will be required, as well as the state registration procedure. Such projects are usually implemented within a period of up to 6 months.

Запуск нового лекарственного препарата займет намного больше времени, нежели БАД. От появления идеи нового препарата до вывода его на рынок может пройти 5 - 10 лет: полная фармразработка формулы, доклинические исследования для проверки гипотезы и подтверждения механизма действия; затем - клинические исследования I и II фазы с участием добровольцев для всесторонней оценки безопасности и эффективности. Только после этого возможна регистрация лекарственного средства, которая сопровождается обязательным подтверждением контроля качества производственного процесса.

Запуск воспроизведенного препарата (дженерика) проще и быстрее, и может занять около полутора лет. Так как этап фармразработки и подробных исследований уже пройден при создании оригинального лекарственного препарата, для воспроизведенного препарата не требуется продолжительных клинических и доклинических исследований. Обычно достаточно исследовния биоэквивалентности; иными словами, необходимо доказать совпадение формулы с воспроизводимым (оригинальным) препаратом.

Подробнее об этом вопросе

Все вопросы и ответы →

Contact us

Select a service*

News

Мы приняли участие в 27-м Аптечном саммите

We attended the 27th Pharmacy Summit

All news